Lexicon Pharmaceuticals Inc (LXRX)
1.77
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
1.775
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Financing (TTM): 428.17M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 428.17M |
| December 31, 2023 | 187.96M |
| September 30, 2023 | 212.87M |
| June 30, 2023 | 307.10M |
| March 31, 2023 | 118.10M |
| December 31, 2022 | 142.21M |
| September 30, 2022 | 105.98M |
| June 30, 2022 | 31.74M |
| March 31, 2022 | 31.72M |
| December 31, 2021 | 22.71M |
| September 30, 2021 | 98.18M |
| June 30, 2021 | -131.72M |
| March 31, 2021 | -132.12M |
| December 31, 2020 | -147.64M |
| September 30, 2020 | -212.11M |
| June 30, 2020 | -2.311M |
| March 31, 2020 | -2.208M |
| December 31, 2019 | -2.226M |
| September 30, 2019 | -2.043M |
| June 30, 2019 | -2.079M |
| March 31, 2019 | -1.978M |
| December 31, 2018 | -2.244M |
| September 30, 2018 | 145.74M |
| June 30, 2018 | 145.60M |
| March 31, 2018 | 149.51M |
| Date | Value |
|---|---|
| December 31, 2017 | 149.93M |
| September 30, 2017 | 2.248M |
| June 30, 2017 | 4.43M |
| March 31, 2017 | 0.811M |
| December 31, 2016 | 0.987M |
| September 30, 2016 | 0.356M |
| June 30, 2016 | -1.681M |
| March 31, 2016 | -2.13M |
| December 31, 2015 | -2.032M |
| September 30, 2015 | 284.10M |
| June 30, 2015 | 284.19M |
| March 31, 2015 | 284.21M |
| December 31, 2014 | 283.81M |
| September 30, 2014 | -1.969M |
| June 30, 2014 | -1.681M |
| March 31, 2014 | -1.609M |
| December 31, 2013 | -1.389M |
| September 30, 2013 | 35.55M |
| June 30, 2013 | 35.93M |
| March 31, 2013 | 36.09M |
| December 31, 2012 | 36.38M |
| September 30, 2012 | 159.80M |
| June 30, 2012 | 159.07M |
| March 31, 2012 | 156.59M |
| December 31, 2011 | 157.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-212.11M
Minimum
Sep 2020
428.17M
Maximum
Mar 2024
52.61M
Average
27.22M
Median
Cash from Financing (TTM) Benchmarks
| Windtree Therapeutics Inc | 11.60M |
| AIM ImmunoTech Inc | 0.485M |
| Perspective Therapeutics Inc | 0.785M |
| Protalix BioTherapeutics Inc | 24.67M |
| Armata Pharmaceuticals Inc | 53.99M |